We say it all the time, the biotech sector is ever changing as FDA guidelines and patient needs evolve. As the landscape continues to shift among large biotechs and small startups, seeing that 38 of the 59 new therapies approved in 2018 came from small or emerging companies is certainly an impactful statistic! The biotech […]